This story has been updated to include additional information from Foundation Medicine's earnings call with analysts. 

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Tuesday that its second quarter revenues rose 24 percent, driven by a higher adoption of its molecular information solutions by clinicians and biopharma partners.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.